Panchsheel Organics Limited (BOM:531726)
107.30
+0.66 (0.62%)
At close: Nov 16, 2026
Panchsheel Organics Revenue
Panchsheel Organics had revenue of 280.66M INR in the quarter ending September 30, 2026, with 10.85% growth. This brings the company's total for the last twelve months to 1.10B, up 6.83% year-over-year. In the fiscal year ending March 31, 2026, Panchsheel Organics had annual revenue of 1.07B, down -0.37%. That makes Panchsheel Organics the 36,698th largest company in the world by revenue and 3,178th in India.
Revenue (ttm)
1.10B
Revenue Growth
+6.83%
P/S Ratio
1.29
Revenue / Employee
5.75M
Employees
191
Market Cap
1.41B
Revenue by Geography
- India 1.05B 98.5%
- Foreign 16.26M 1.5%
Fiscal year ended Mar 31, 2026 See the full Panchsheel Organics breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 1.07B | -3.96M | -0.37% |
| Mar 31, 2025 | 1.07B | 19.60M | 1.86% |
| Mar 31, 2024 | 1.05B | 20.40M | 1.98% |
| Mar 31, 2023 | 1.03B | 341.34M | 49.44% |
| Mar 31, 2022 | 690.45M | 194.87M | 39.32% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Aarey Drugs & Pharmaceuticals | 4.20B |
| Resonance Specialties | 1.14B |
| Smruthi Organics | 1.12B |
| Kimia Biosciences | 1.04B |
| Tyche Industries | 503.78M |
| Accretion Nutraveda | 489.95M |
| Himalaya Nutravedics India | 430.68M |
| Auro Laboratories | 407.90M |